— Know what they know.
Not Investment Advice

CVRX NASDAQ

CVRx, Inc.
1W: -42.6% 1M: -49.5% 3M: -72.5% YTD: -78.2% 1Y: -80.5% 3Y: -89.7% 5Y: -90.4%
$1.55
+0.02 (+1.31%)
 
Weekly Expected Move ±18.7%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 35 · $41.1M mcap · 18M float · 3.84% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
57.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -260.4%  ·  5Y Avg: -212.4%
Cost Advantage
39
Intangibles
81
Switching Cost
54
Network Effect
74
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CVRX has a Narrow competitive edge (57.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. Negative ROIC of -260.4% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$4
Low
$4
Avg Target
$5
High
Based on 5 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 5Hold: 1Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$4.30
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-22 Canaccord Genuity William Plovanic $10 $5 -5 +68.4% $2.97
2026-08-17 Cantor Fitzgerald — $13 $5 -8 +68.9% $2.96
2026-08-07 Lake Street Frank Takkinen $12 $4 -8 +28.2% $2.73
2026-08-07 Craig-Hallum — $23 $4 -19 -32.7% $5.94
2026-08-07 Piper Sandler — $16 $4 -12 -32.7% $5.94
2026-02-13 Canaccord Genuity William Plovanic $15 $10 -5 +75.7% $5.69
2025-11-06 Cantor Fitzgerald Ross Osborn $14 $13 -1 +30.3% $9.98
2024-10-30 Piper Sandler Matt O'Brien $13 $16 +3 +24.0% $12.90
2024-09-10 Cantor Fitzgerald Ross Osborn Initiated $14 — +75.9% $7.96
2024-07-30 Piper Sandler Matt O'Brien Initiated $13 — +40.2% $9.27
2024-07-30 Canaccord Genuity William Plovanic Initiated $15 — +61.8% $9.27
2024-07-11 Lake Street Frank Takkinen Initiated $12 — +58.1% $7.59
2024-06-05 Loop Capital Markets Frank Takkinen Initiated $18 — +125.1% $8.00
2024-05-01 Craig-Hallum Chase Knickerbocker Initiated $23 — +148.1% $9.27

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CVRX receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-01-03 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
20
Balance Sheet
30
Earnings Quality
45
Growth
60
Value
24
Momentum
58
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CVRX scores highest in Growth (60/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-8.20
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✗ ✓ ✗ ✗ ✗ ✓ ✓
Beneish M-Score
-2.77
Unlikely Manipulator
Ohlson O-Score
-2.62
Bankruptcy prob: 6.8%
Low Risk
Credit Rating
B
Score: 25.1/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.78x
Accruals: -10.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CVRX scores -8.20, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CVRX scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CVRX's score of -2.77 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CVRX's implied 6.8% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CVRX receives an estimated rating of B (score: 25.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.78x
PEG
-0.13x
P/S
0.67x
P/B
2.06x
P/FCF
-3.32x
P/OCF
—
EV/EBITDA
-2.92x
EV/Revenue
2.14x
EV/EBIT
-2.85x
EV/FCF
-3.19x
Earnings Yield
-38.13%
FCF Yield
-30.12%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CVRX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.131
EBT / EBIT
×
EBIT Margin
-0.751
EBIT / Rev
×
Asset Turnover
0.578
Rev / Assets
×
Equity Multiplier
2.720
Assets / Equity
=
ROE
-133.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CVRX's ROE of -133.4% is driven by Asset Turnover (0.578), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1321 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.55
Median 1Y
$0.51
5th Pctile
$0.10
95th Pctile
$2.64
Ann. Volatility
106.5%
Analyst Target
$4.30
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Philip Adamson Medical
edical Officer
$549,539 $259,200 $1,361,143

CEO Pay Ratio

23:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,082,769
Avg Employee Cost (SGA/emp): $396,740
Employees: 223

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
223
+8.2% YoY
Revenue / Employee
$254,040
Rev: $56,651,000
Profit / Employee
$-239,040
NI: $-53,306,000
SGA / Employee
$396,740
Avg labor cost proxy
R&D / Employee
$49,919
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -15.3% -23.6% -32.5% 39.4% -30.3% -32.5% -36.2% -40.0% -42.3% -44.5% -62.7% -74.9% -79.0% -81.6% -76.0% -92.3% -91.9% -96.6% -1.1% -1.3% -1.33%
ROA -13.1% -22.6% -30.8% -39.9% -26.9% -29.9% -32.1% -34.9% -36.5% -34.3% -45.5% -51.6% -50.0% -48.2% -43.7% -48.5% -43.5% -44.8% -45.9% -49.1% -49.06%
ROIC -2.4% -4.4% -4.1% -4.7% -3.6% -3.3% -3.3% -2.5% -2.3% -2.1% -2.5% -2.8% -3.0% -3.0% -2.3% -3.0% -3.0% -2.8% -2.4% -2.6% -2.60%
ROCE -13.1% -22.3% -31.0% -28.6% -34.4% -35.2% -36.9% -40.0% -41.5% -36.6% -50.5% -59.0% -47.0% -45.3% -38.5% -42.7% -46.1% -51.9% -51.8% -56.6% -56.61%
Gross Margin 74.2% 73.1% 76.7% 76.1% 78.3% 79.0% 83.4% 84.0% 83.9% 84.8% 83.8% 82.7% 83.2% 85.0% 83.5% 84.3% 86.8% 86.3% 87.2% 87.4% 87.39%
Operating Margin -2.1% -2.4% -2.4% -2.2% -1.6% -1.6% -1.5% -1.2% -90.6% -85.5% -2.1% -1.2% -97.3% -67.0% -1.1% -1.1% -83.5% -69.8% -82.3% -82.9% -82.92%
Net Margin -1.8% -2.9% -2.5% -2.2% -1.6% -1.5% -1.4% -1.2% -85.7% -81.1% -2.1% -1.2% -98.0% -69.4% -1.1% -1.1% -87.6% -74.5% -88.8% -89.4% -89.42%
EBITDA Margin -1.6% -2.8% -2.4% -2.2% -1.6% -1.4% -1.4% -1.2% -79.3% -74.4% -2.0% -1.1% -89.2% -58.8% -98.2% -96.2% -76.2% -64.5% -76.9% -76.7% -76.72%
FCF Margin -2.5% -2.3% -2.4% -2.4% -2.1% -1.9% -1.6% -1.5% -1.2% -1.0% -97.3% -86.0% -85.6% -79.0% -78.6% -72.1% -69.7% -71.9% -68.0% -67.1% -67.09%
OCF Margin -2.4% -2.2% -2.3% -2.3% -2.1% -1.9% -1.6% -1.5% -1.2% -99.3% -94.3% -82.6% -82.5% -76.3% -77.6% -71.6% -68.6% -70.9% -67.0% -66.1% -66.12%
ROE 3Y Avg snapshot only -1.50%
ROE 5Y Avg snapshot only -1.05%
ROA 3Y Avg snapshot only -52.23%
ROIC 3Y Avg snapshot only -2.60%
ROIC Economic snapshot only -49.18%
Cash ROA snapshot only -43.84%
Cash ROIC snapshot only -2.74%
CROIC snapshot only -2.78%
NOPAT Margin snapshot only -62.79%
Pretax Margin snapshot only -84.94%
R&D / Revenue snapshot only 20.20%
SGA / Revenue snapshot only 1.46%
SBC / Revenue snapshot only 15.32%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -13.94 -7.23 -2.76 -3.26 -4.63 -9.12 -4.50 -7.37 -7.41 -15.89 -7.43 -4.77 -3.43 -4.77 -6.14 -2.93 -4.06 -3.49 -4.73 -2.62 -0.783
P/S Ratio 51.07 24.48 8.60 7.63 10.13 16.82 7.31 10.37 8.97 16.66 9.19 5.84 4.25 5.58 5.99 2.81 3.77 3.29 4.22 2.23 0.672
P/B Ratio 2.14 1.71 0.90 0.97 1.62 3.46 1.94 3.55 3.81 8.62 5.84 4.69 3.08 4.03 4.56 2.65 4.39 4.73 8.57 6.83 2.060
P/FCF -20.52 -10.48 -3.53 -3.24 -4.80 -8.71 -4.49 -6.99 -7.42 -16.53 -9.44 -6.79 -4.96 -7.07 -7.61 -3.89 -5.42 -4.57 -6.21 -3.32 -3.320
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -8.05 -3.28 0.19 -0.06 -2.03 -6.84 -2.49 -5.84 -6.12 -15.36 -6.91 -4.33 -2.78 -4.20 -5.75 -2.36 -3.89 -3.45 -5.14 -2.92 -2.916
EV/Revenue 27.84 10.52 -0.57 0.15 4.35 12.41 3.95 7.92 7.05 15.14 8.01 4.94 3.20 4.50 5.00 1.99 3.15 2.85 4.00 2.14 2.142
EV/EBIT -8.03 -3.27 0.19 -0.06 -2.01 -6.77 -2.46 -5.77 -6.04 -15.15 -6.83 -4.28 -2.75 -4.16 -5.67 -2.32 -3.82 -3.39 -5.06 -2.85 -2.853
EV/FCF -11.19 -4.50 0.23 -0.06 -2.06 -6.43 -2.43 -5.34 -5.83 -15.02 -8.24 -5.75 -3.73 -5.70 -6.36 -2.76 -4.53 -3.96 -5.89 -3.19 -3.193
Earnings Yield -7.2% -13.8% -36.3% -30.6% -21.6% -11.0% -22.2% -13.6% -13.5% -6.3% -13.5% -21.0% -29.1% -20.9% -16.3% -34.1% -24.6% -28.6% -21.1% -38.1% -38.13%
FCF Yield -4.9% -9.5% -28.3% -30.8% -20.8% -11.5% -22.3% -14.3% -13.5% -6.0% -10.6% -14.7% -20.2% -14.1% -13.1% -25.7% -18.5% -21.9% -16.1% -30.1% -30.12%
Price/Tangible Book snapshot only 6.831
EV/Gross Profit snapshot only 2.465
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 20.42 25.57 21.57 22.33 16.82 15.19 15.15 12.55 13.99 14.25 12.18 10.08 11.32 12.06 14.83 11.99 9.62 7.63 10.20 8.04 8.045
Quick Ratio 20.03 24.92 20.77 21.34 16.00 14.33 14.12 11.33 12.52 12.86 10.87 8.85 10.23 10.94 13.45 10.78 8.60 6.72 8.89 6.87 6.873
Debt/Equity 0.13 0.00 0.00 0.00 0.00 0.06 0.15 0.17 0.19 0.40 0.46 0.55 0.77 0.71 0.73 0.87 1.05 1.29 2.04 2.98 2.976
Net Debt/Equity -0.97 -0.97 -0.96 -0.95 -0.93 -0.91 -0.89 -0.84 -0.82 -0.79 -0.75 -0.72 -0.76 -0.78 -0.75 -0.77 -0.72 -0.63 -0.44 -0.26 -0.260
Debt/Assets 0.11 0.00 0.00 0.00 0.00 0.06 0.12 0.13 0.14 0.27 0.29 0.32 0.40 0.38 0.39 0.42 0.45 0.48 0.60 0.64 0.644
Debt/EBITDA -0.86 -0.00 -0.01 -0.01 -0.01 -0.17 -0.35 -0.37 -0.38 -0.79 -0.63 -0.60 -0.93 -0.92 -1.10 -1.10 -1.11 -1.09 -1.29 -1.32 -1.321
Net Debt/EBITDA 6.72 4.35 3.07 3.32 2.70 2.43 2.12 1.80 1.67 1.55 1.01 0.79 0.92 1.01 1.14 0.96 0.76 0.53 0.28 0.12 0.116
Interest Coverage -18.50 -20.25 -26.41 -36.30 -103.43 -249.42 -104.42 -47.83 -29.64 -21.82 -19.59 -17.10 -15.87 -12.63 -9.53 -8.67 -7.79 -8.15 -7.90 -7.62 -7.625
Equity Multiplier 1.17 1.05 1.06 1.05 1.07 1.14 1.23 1.28 1.28 1.52 1.60 1.74 1.96 1.88 1.87 2.06 2.32 2.66 3.43 4.63 4.625
Cash Ratio snapshot only 5.806
Debt Service Coverage snapshot only -7.460
Cash to Debt snapshot only 1.087
FCF to Debt snapshot only -0.691
Defensive Interval snapshot only 265.2 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.04 0.07 0.10 0.17 0.12 0.16 0.20 0.25 0.30 0.33 0.37 0.42 0.40 0.41 0.45 0.51 0.47 0.48 0.52 0.58 0.578
Inventory Turnover 0.52 0.71 0.71 0.89 0.94 0.92 0.80 0.68 0.71 0.70 0.69 0.65 0.68 0.72 0.76 0.76 0.72 0.68 0.68 0.65 0.647
Receivables Turnover 1.91 3.98 3.88 5.53 4.35 5.57 5.22 5.97 6.03 6.02 5.64 5.79 6.14 6.10 6.04 6.94 6.49 5.68 6.52 7.39 7.393
Payables Turnover 3.31 5.44 2.32 5.36 4.92 4.49 2.99 3.22 5.02 3.47 2.90 2.23 3.52 3.73 3.22 2.66 2.44 2.59 2.84 2.32 2.318
DSO 192 92 94 66 84 65 70 61 61 61 65 63 59 60 60 53 56 64 56 49 49.4 days
DIO 702 511 516 409 388 396 458 537 512 523 528 562 536 506 481 480 505 534 538 564 564.2 days
DPO 110 67 158 68 74 81 122 113 73 105 126 164 104 98 113 137 150 141 129 157 157.4 days
Cash Conversion Cycle 783 535 452 407 398 380 406 485 500 479 467 461 492 468 428 396 412 457 466 456 456.1 days
Fixed Asset Turnover snapshot only 22.098
Operating Cycle snapshot only 613.6 days
Cash Velocity snapshot only 0.947
Capital Intensity snapshot only 1.508
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — — 4.2% 1.9% 1.2% 85.0% 90.8% 85.6% 74.9% 59.6% 43.9% 34.4% 30.5% 25.6% 23.1% 18.4% 10.4% 11.7% 12.0% 11.96%
Net Income — — — -1.1% -73.6% -20.3% 3.7% -14.9% -2.7% 0.6% -21.5% -25.3% -37.4% -45.5% 0.9% 3.9% 11.0% 11.1% -2.2% 0.5% 0.54%
EPS — — — 96.2% -69.8% -18.9% 4.8% -13.8% -1.6% 1.7% -18.4% -20.0% -25.4% -34.2% 18.7% 20.3% 22.5% 23.4% -0.3% 2.2% 2.21%
FCF — — — -4.6% -1.5% -82.4% -23.6% -20.3% -6.3% 8.6% 4.6% 16.5% 4.9% -2.3% -1.6% -3.3% 3.6% -0.6% 3.4% -4.1% -4.13%
EBITDA — — — -1.1% -80.3% -24.9% 1.7% -15.0% 0.2% 4.9% -16.8% -21.1% -33.9% -41.7% 5.8% 9.0% 16.3% 14.9% -0.0% 2.6% 2.60%
Op. Income — — — -5.5% -2.1% -95.5% -41.4% -23.0% -12.8% -1.4% -18.7% -21.7% -31.1% -38.0% 4.7% 7.8% 14.5% 13.8% 1.4% 4.8% 4.82%
OCF Growth snapshot only -3.42%
Asset Growth snapshot only -22.82%
Equity Growth snapshot only -65.56%
Debt Growth snapshot only 17.50%
Shares Change snapshot only 1.70%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — — 1.4% 93.5% 71.5% 54.8% 50.1% 43.5% 36.1% 30.8% 25.7% 25.65%
Revenue 5Y — — — — — — — — — — — — — — — — — — — 81.3% 81.31%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — 1.6% 1.0% 79.7% 61.4% 55.8% 48.7% 40.4% 34.3% 28.4% 28.36%
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — 88.9% 88.92%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — 20.3% -11.1% -4.4% -3.5% -3.7% -4.2% -5.7% -6.7% -7.1% -7.07%
Assets 5Y — — — — — — — — — — — — — — — — — — — 10.9% 10.88%
Equity 3Y — — — — — — — — — — — — -25.2% -21.3% -20.3% -23.0% -25.9% -28.9% -33.6% -39.5% -39.47%
Book Value 3Y — — — — — — — — — — — — -28.2% -24.0% -26.3% -29.0% -31.6% -34.4% -38.8% -44.3% -44.25%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — — — 1.00 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.99 0.98 0.95 0.96 0.98 0.983
Earnings Stability — — — — — — — 0.90 0.79 0.72 0.59 0.94 0.92 0.81 0.69 0.85 0.78 0.74 0.72 0.76 0.756
Margin Stability — — — — — — — 0.93 0.93 0.93 0.94 0.92 0.93 0.93 0.94 0.95 0.95 0.96 0.97 0.92 0.923
Rev. Growth Consistency 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — 0.94 0.99 1.00 0.91 0.90 0.85 0.82 1.00 0.98 0.96 0.96 0.99 1.00 0.998
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.26 -0.23 -0.41 -0.59 -0.46 -0.38 -0.14 -0.17 -0.38 -0.66 -1.05 -1.66 -1.661
Gross Margin Trend — — — — — — — 0.09 0.08 0.09 0.07 0.05 0.04 0.03 0.02 0.01 0.02 0.01 0.02 0.03 0.030
FCF Margin Trend — — — — — — — 0.79 1.09 1.13 1.06 1.06 0.80 0.68 0.51 0.45 0.34 0.18 0.20 0.12 0.120
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.66 0.66 0.75 0.98 0.94 1.03 0.99 1.04 0.99 0.95 0.76 0.67 0.67 0.65 0.80 0.75 0.74 0.75 0.75 0.78 0.778
FCF/OCF 1.03 1.05 1.04 1.03 1.03 1.02 1.01 1.02 1.01 1.02 1.03 1.04 1.04 1.03 1.01 1.01 1.01 1.01 1.01 1.01 1.015
FCF/Net Income snapshot only 0.790
CapEx/Revenue 8.3% 10.6% 9.6% 6.5% 6.0% 3.0% 2.4% 2.4% 1.4% 1.5% 3.0% 3.3% 3.1% 2.7% 1.1% 0.6% 1.0% 1.0% 1.0% 1.0% 0.98%
CapEx/Depreciation snapshot only 0.599
Accruals Ratio -0.05 -0.08 -0.08 -0.01 -0.02 0.01 -0.00 0.01 -0.00 -0.02 -0.11 -0.17 -0.17 -0.17 -0.09 -0.12 -0.11 -0.11 -0.11 -0.11 -0.109
Sloan Accruals snapshot only -0.275
Cash Flow Adequacy snapshot only -67.767
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -40.0% -53.5% -1.1% -1.1% -0.2% -0.1% -0.2% -0.2% -0.2% -0.1% -0.3% -0.2% -10.0% -11.4% -13.1% -27.4% -10.6% -5.7% -0.4% -1.3% -1.27%
Total Shareholder Return -40.0% -53.5% -1.1% -1.1% -0.2% -0.1% -0.2% -0.2% -0.2% -0.1% -0.3% -0.2% -10.0% -11.4% -13.1% -27.4% -10.6% -5.7% -0.4% -1.3% -1.27%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.05 1.05 1.04 1.03 1.01 1.00 1.01 1.02 1.03 1.05 1.05 1.06 1.06 1.08 1.10 1.12 1.13 1.12 1.13 1.13 1.131
EBIT Margin -3.47 -3.22 -3.00 -2.27 -2.16 -1.83 -1.60 -1.37 -1.17 -1.00 -1.17 -1.15 -1.16 -1.08 -0.88 -0.86 -0.83 -0.84 -0.79 -0.75 -0.751
Asset Turnover 0.04 0.07 0.10 0.17 0.12 0.16 0.20 0.25 0.30 0.33 0.37 0.42 0.40 0.41 0.45 0.51 0.47 0.48 0.52 0.58 0.578
Equity Multiplier 1.17 1.05 1.06 -0.99 1.13 1.09 1.13 1.15 1.16 1.30 1.38 1.45 1.58 1.69 1.74 1.90 2.11 2.16 2.33 2.72 2.720
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-1.19 $-1.69 $-2.17 $-1.84 $-2.01 $-2.01 $-2.07 $-2.09 $-2.05 $-1.98 $-2.45 $-2.51 $-2.57 $-2.65 $-1.99 $-2.00 $-1.99 $-2.03 $-2.00 $-1.96 $-1.96
Book Value/Share $7.74 $7.17 $6.69 $6.20 $5.75 $5.30 $4.82 $4.34 $3.98 $3.65 $3.12 $2.55 $2.86 $3.14 $2.68 $2.22 $1.84 $1.50 $1.10 $0.75 $0.75
Tangible Book/Share $7.74 $7.17 $6.69 $6.20 $5.75 $5.30 $4.82 $4.34 $3.98 $3.65 $3.12 $2.55 $2.86 $3.14 $2.68 $2.22 $1.84 $1.50 $1.10 $0.75 $0.75
Revenue/Share $0.32 $0.50 $0.70 $0.79 $0.92 $1.09 $1.27 $1.49 $1.69 $1.89 $1.98 $2.05 $2.07 $2.27 $2.04 $2.10 $2.14 $2.16 $2.24 $2.31 $2.31
FCF/Share $-0.81 $-1.17 $-1.70 $-1.85 $-1.94 $-2.11 $-2.07 $-2.21 $-2.04 $-1.90 $-1.93 $-1.76 $-1.78 $-1.79 $-1.61 $-1.51 $-1.49 $-1.55 $-1.52 $-1.55 $-1.55
OCF/Share $-0.78 $-1.11 $-1.63 $-1.80 $-1.89 $-2.07 $-2.04 $-2.17 $-2.02 $-1.87 $-1.87 $-1.70 $-1.71 $-1.73 $-1.59 $-1.50 $-1.47 $-1.53 $-1.50 $-1.53 $-1.53
Cash/Share $8.49 $6.98 $6.41 $5.92 $5.35 $5.16 $4.99 $4.38 $3.99 $4.35 $3.77 $3.25 $4.40 $4.69 $3.97 $3.64 $3.25 $2.89 $2.74 $2.44 $2.44
EBITDA/Share $-1.12 $-1.60 $-2.08 $-1.78 $-1.97 $-1.98 $-2.02 $-2.02 $-1.95 $-1.86 $-2.30 $-2.34 $-2.38 $-2.43 $-1.78 $-1.77 $-1.74 $-1.78 $-1.74 $-1.70 $-1.70
Debt/Share $0.97 $0.00 $0.03 $0.02 $0.02 $0.34 $0.70 $0.74 $0.74 $1.47 $1.44 $1.41 $2.21 $2.23 $1.95 $1.94 $1.93 $1.94 $2.25 $2.24 $2.24
Net Debt/Share $-7.52 $-6.98 $-6.39 $-5.90 $-5.33 $-4.81 $-4.29 $-3.64 $-3.25 $-2.88 $-2.33 $-1.84 $-2.18 $-2.46 $-2.02 $-1.71 $-1.32 $-0.95 $-0.49 $-0.20 $-0.20
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -8.203
Altman Z-Prime snapshot only -17.622
Piotroski F-Score 2 2 2 5 4 2 3 2 3 3 3 2 2 3 4 5 4 4 3 3 3
Beneish M-Score — — — -2.11 -2.31 -1.45 -1.71 -1.60 -2.12 -2.16 -2.80 -3.10 -2.87 -2.97 -2.75 -3.13 -3.12 -2.94 -3.04 -2.77 -2.773
Ohlson O-Score snapshot only -2.621
ROIC (Greenblatt) snapshot only -56.63%
Net-Net WC snapshot only $0.65
EVA snapshot only $-39898140.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B
Credit Score 59.52 68.14 62.18 63.66 64.24 65.15 38.03 48.70 48.60 63.00 32.04 30.87 30.04 30.22 30.14 30.40 28.13 28.28 25.67 25.10 25.103
Credit Grade snapshot only 15
Credit Trend snapshot only -5.294
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 14
Sector Credit Rank snapshot only 15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms